News search

    E.g., 21/04/2026
    E.g., 21/04/2026
    Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
    Research
    21 Apr 2026
    CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure

    The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.
    José Luis de la Pompa, Blanca Rubio, Rocío Serrano, Laura Lalaguna, Pablo García Pavía, María López Olañeta y Enrique Lara.
    Research
    10 Sep 2025
    European Heart Journal: CNIC scientists report the first use of CRISPR activation to treat a cardiac disease in mice

    The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases